Graves’ orbitopathy: lessons from Representational Art

Auteurs-es

  • Francesco Trimarchi Department of Clinical and Experimental Medicine, University of Messina; Accademia Peloritana dei Pericolanti, Messina
  • Enio Martino University of Pisa
  • Maria Laura Tanda Department of Medicine and Surgery, University of Insubria, Varese
  • Luigi Bartalena Department of Medicine and Surgery, University of Insubria, Varese

DOI :

https://doi.org/10.6092/1828-6550/APMB.109.1.2021.SD2

Mots-clés :

Graves’ disease, Graves’orbitopathy, Endo&Art, Exophthalmos, Strabismus

Résumé

Graves’ orbitopathy (GO) is an autoimmune orbital disorder which occurs most commonly in patients with Graves’ disease,  less frequently in patients with chronic autoimmune thyroiditis. Full-blown GO is characterized by exophthalmos, swelling and inflammation of periorbital soft tissues, extraocular muscle dysfunction (responsible for diplopia) and may evolve into  relevant functional and disfiguring sequelae which impair quality of life. GO may very rarely sight-threatening due to optic neuropathy or corneal breakdown. This study reviews a series of  articles dealing with  figurative works of art (sculpture and painting) from the Hellenistic age up to a few years ago, that represent real-life individuals or ideal models with features of GO. Clinical evaluation and a hypothetical ideal treatment is proposed for some selected subjects who appear in the portraits, based on updated clinical and management criteria.

Références

References

1. Smith, T.J., Hegedus, L. (2016) Graves’ disease. N Engl J Med 375(16),1552–1565.

2. Graves, R.J.(1835) Clinical Lectures Newly observed affection of the thyroid gland in females.London Medical and Surgical Journal. 7: 516-517.

3. Parry, C. H. (1825) Disease of the heart., Elements Pathology Therapy 2, 111-118.

4. Bartalena, L., Piantanida, E., Gallo, D., Lai, A., Tanda, M.L. Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy. (2020) Front Endocrinol(Lausanne).2020,11:615993.doi: 10.3389/fendo.2020.615993

5. Taylor,P.N., Zhang, L., Lee, R.W.J., Muller, I., Ezra, D.G., Dayan, C.M., Kahaly, G.J., Ludgate. M. (2020) New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nat Rev Endocrinol. Feb;16(2):104-116. doi: 10.1038/s41574-019-0305-4.

6. Bahn, R.S. (2010) Graves' ophthalmopathy. N Engl J Med. Feb 25;362(8):726-38. doi: 10.1056/NEJMra0905750..

7. Wiersinga, W.M. (2012) Quality of life in Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab. Jun;26(3):359-70.doi:10.1016/j.beem.2011.11.001. PMID: 22632371.

8. Ponto, K.A., Merkesdal, S., Hommel, G., Pitz, S., Pfeiffer, N., Kahaly, G.J. (2013) Public health relevance of Graves' orbitopathy. J ClinEndocrinolMetab. Jan;98(1):145-52. doi: 10.1210/jc.2012-3119. Epub 2012 Nov 26. PMID: 23185037.

9. Perros, P., Žarković, M.P., Panagiotou, G.C. et al. Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study. J Endocrinol Invest 43, 1717–1722 (2020). https://doi.org/10.1007/s40618-020-01258-w

10. Tanda, M.L., Piantanida, E., Liparulo, L., Veronesi, G., Lai, A., Sassi, L., Pariani, N., Gallo, D., Azzolini, C., Ferrario, M., Bartalena, L. (2013) Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98(4),1443-9. doi: 10.1210/jc.2012-3873

11. Bartalena, L., Baldeschi, L., Boboridis, K., Eckstein, A., Kahaly, G.J., Marcocci, C., Perros, P., Salvi, M., Wiersinga, W.M; European Group on Graves' Orbitopathy (EUGOGO). .(2016) The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J. 2016 Mar;5(1):9-26.

12. Mourits, M.P., Koornneef, L., Wiersinga, W.M., Prummel, M.F., Berghout, A., van der Gaag, R. (1989) Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. Aug;73(8):639-44. doi: 10.1136/bjo.73.8.639.

13. Kahaly, G.J., Riedl, M., König, J., Pitz, S., Ponto, K., Diana, T., Kampmann, E., Kolbe, E., Eckstein, A., Moeller, L.C., Führer, D., Salvi, M., Curro, N., Campi, I., Covelli, D., Leo, M., Marinò, M., Menconi, F., Marcocci, C., Bartalena, L., Perros, P., Wiersinga, W.M.; European Group on Graves' Orbitopathy (EUGOGO). (2018) Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. Lancet DiabetesEndocrinol. Apr;6(4):287-298. doi: 10.1016/S2213-8587(18)30020-2.

14. Marketos, S.G., Eftychradis,A.,Koutras,D.A.(1983) The first recognition of the association between goiter and exophthalmos J. Endocrinol. Invest. 6, 401-403.

15. Riva, M.A., Paleari, A., Belingheri, M. (2020) At the origin of “Endocrinology and Art”: Woman’s Head (third century BCE). J Endocrinol Invest43, 1673–1674 https://doi.org/10.1007/s40618-020-01416-0

16. Tassinari, J., Sisti, A. (2016) Exophthalmos (Graves’ orbitopathy) in an ancient sculpture. J Endocrinol Invest39, 1085–1086 https://doi.org/10.1007/s40618-016-0471-3

17. Martino, E., Vitti, P. (2014) Leonardo da Vinci Design of Lady with Graves’ disease (1452–1519). J Endocrinol Invest37, 781 https://doi.org/10.1007/s40618-014-0099-0

18.Di Giacomo, C., Trimarchi, F. (2016) Virgin and Child with Saint Anne by Albrecht Dürer (1471–1528). J Endocrinol Invest39, 355–356). https://doi.org/10.1007/s40618-015-0416-2

19. Trimarchi, F., Di Giacomo, C., Toni, R. (2016) La semeiotica endocrino-metabolica nell’opera del pittore tedesco AlbrechtDürer. L'Endocrinologo17, 45–51. https://doi.org/10.1007/s40619-016-0165-2

20. Dallari, V., Gazzini, L. ,Sacchetto, A. (2021) Was Tiepolo’s wife affected by Graves' disease?JEndocrinol Invest https://doi.org/10.1007/s40618-020-01487-z

21. Di Giacomo, C., Trimarchi, F. ,Bartalena, L. (2017) Maria Carolina of Austria, Queen of Naples and Sicily: a possible case of Graves’ orbitopathy. J Endocrinol Invest40,239–240. https://doi.org/10.1007/s40618-016-0574-x

22. Russo, M., Borzì, G. (2020)The rebel thyroid of a revolutionary First Lady. J Endocrinol Invest43,395–396 https://doi.org/10.1007/s40618-019-01113-7

23. Lazzeri, D., Pozzilli, P. (2018) Exophthalmos or pseudo-exophthalmos in the Last Judgement (1535–1541) by Michelangelo Buonarroti (1475–1564). J Endocrinol Invest. 41, 1485–1486 https://doi.org/10.1007/s40618-018-0962-5

24. Trimarchi, F., Bartalena, L., Arieti, S. et al.(2021)Un case report letterario di tireotossicosi in La coscienza di Zeno di Italo Svevo. L'Endocrinologo.22, 149–155 https://doi.org/10.1007/s40619-021-00846-z

25. Trimarchi, F., Martino,E.,Bartalena, L. (2020) Graves’ orbitopathy represented as feature of a state of mind. J Endocrinol Invest.43, 1343–1344 https://doi.org/10.1007/s40618-020-01250-4

26. Trimarchi, F., Martino, E. ,Bartalena, L. (2021) Comics’ representation of Graves’ orbitopathy, by Emil FerrisJEndocrinol Invest. https://doi.org/10.1007/s40618-020-01469-1

27 Tanda, M.L., Trimarchi, F. (2021) Graves’ orbitopathy in Natalie Frank’soeuvre. J EndocrinolInvest https://doi.org/10.1007/s40618-021-01564-x

28. Accorona, R., Guastella, C.,Pignataro, L. (2020) Mother with child (1921): a Graves’ disease painted by Otto Dix. J Endocrinol Invest. https://doi.org/10.1007/s40618-020-01420-4

Téléchargements

Numéro

Vol. 109 No. 1 (2021)

Rubrique

SCHOLARLY DIALOGS

Licence

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:
  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).